The treatment of bipolar disorder in women

2017 ◽  
Author(s):  
Danielle Balzafiore ◽  
Thalia Robakis ◽  
Sarah Borish ◽  
Vena Budhan ◽  
Natalie Rasgon
Keyword(s):  
Bipolar Disorder ◽  
Polycystic Ovary ◽  
Treatment Options ◽  
Perinatal Period ◽  
Ovary Syndrome ◽  
Behavioural Interventions ◽  
Stabilizing Agents ◽  
Specific Effects ◽  
Affective Symptoms ◽  
Efficacious Treatment

Sex-specific effects in the clinical presentation and course of bipolar disorder in women have important treatment implications for the management of symptoms across the menstrual cycle and reproductive lifespan. Women with bipolar disorder are particularly vulnerable to premenstrual mood symptoms, menstrual abnormalities, and polycystic ovary syndrome. Special considerations include understanding the interactions between these reproductive issues, oral contraceptives, and mood-stabilizing agents. Additionally, the management of bipolar disorder during the perinatal period requires a careful approach to psychotropic medication to optimize the maintenance of mood stability while minimizing the potential for adverse risk of fetal and neonatal outcomes. Non-pharmaceutical approaches, including electroconvulsive therapy, transcranial magnetic stimulation, selected psychotherapies, and social and behavioural interventions may represent efficacious treatment options to reduce medication burden. Lastly, women with bipolar disorder may be at particular risk for worsening of affective symptoms during the menopausal transition, and strategies to reduce sleep disruption are imperative.

Conservative possibilities influencing PCOS syndrome – the importance of nutrition

2021 ◽  
Vol 86 (5) ◽  
pp. 343-348
Author(s):  
Dávid Líška ◽  
◽  
Jozef Záhumenský
Keyword(s):  
Metabolic Syndrome ◽  
Conservative Treatment ◽  
Polycystic Ovary Syndrome ◽  
Eating Habits ◽  
Polycystic Ovary ◽  
Pathological Condition ◽  
Treatment Options ◽  
Ovary Syndrome ◽  
Low Carbohydrate Diet ◽  
Therapeutic Diets

Polycystic ovary syndrome (PCOS) is a common pathological condition in women. Conservative treatment is used in the treatment of polycystic ovary syndrome. Conservative treatment options include increased physical activity and diet. The main aim of the article is to discuss the therapeutic treatment of infl uencing PCOS from a nutritional point of view. PCOS is associated with several comorbidities, including infertility, metabolic syndrome, obesity, impaired glucose tolerance, diabetes mellitus II, and increased cardiovascular risk. Several therapeutic diets can be used in the treatment of PCOS, such as the DASH diet, the low-carbohydrate diet, and a diet based on a low glycemic index. A change in eating habits is associated with improvement in PCOS symptoms. Key words: polycystic ovary syndrome – nutrition – diet – metabolic syndrome

scholarly journals Exploring new treatment options for polycystic ovary syndrome: Review of a novel antidiabetic agent SGLT2 inhibitor

2021 ◽  
Vol 12 (7) ◽  
pp. 932-938
Author(s):  
Jelena Marinkovic-Radosevic ◽  
Maja Cigrovski Berkovic ◽  
Egon Kruezi ◽  
Ines Bilic-Curcic ◽  
Anna Mrzljak
Keyword(s):  
Polycystic Ovary Syndrome ◽  
Polycystic Ovary ◽  
Treatment Options ◽  
Sglt2 Inhibitor ◽  
Antidiabetic Agent ◽  
Ovary Syndrome ◽  
New Treatment

Medication Status and Polycystic Ovary Syndrome in Women With Bipolar Disorder

2000 ◽  
Vol 61 (3) ◽  
pp. 173-178 ◽  
Author(s):  
Natalie L. Rasgon ◽  
Lori L. Altshuler ◽  
David Gudeman ◽  
Vivien K. Burt ◽  
Sohrab Tanavoli ◽  
...  
Keyword(s):  
Bipolar Disorder ◽  
Polycystic Ovary Syndrome ◽  
Polycystic Ovary ◽  
Ovary Syndrome ◽  
Medication Status

scholarly journals PRESCRIPTION PATTERN IN OBESE AND NON-OBESE INFERTILE WOMEN WITH POLYCYSTIC OVARY SYNDROME IN A TERTIARY CARE HOSPITAL

2018 ◽  
Vol 11 (3) ◽  
pp. 53
Author(s):  
Asha Avirah Mm ◽  
Aswathy Alias ◽  
Manjusha Sajith ◽  
Vandana Nimbargi ◽  
Shivhar Kumdale
Keyword(s):  
Polycystic Ovary Syndrome ◽  
Polycystic Ovary ◽  
Clomiphene Citrate ◽  
Treatment Options ◽  
Tertiary Care ◽  
Care Hospital ◽  
Lifestyle Modifications ◽  
Ovary Syndrome ◽  
Infertile Women ◽  
Current Medication

 Objective: The objective of this study is to evaluate the treatment options for the management of obese and non-obese infertile women with polycystic ovary syndrome (PCOS).Methods: A prospective observational study was conducted with 75 infertile PCOS women. The demographic details, body mass index, menstrual patterns, and current medication related to infertility were noted. The collected data were statistically represented in terms of range, frequency tables, and standard deviation wherever appropriate.Results: A majority of the infertile PCOS women were aged 24–27 years with a mean age of 25.72±3.53 years, belonging to middle socioeconomic class (44%) and mostly found to be urban residents 68%. Most of the PCOS women were overweight (32%) and obese (21%) with irregular menstrual pattern (90.67%). In combination therapy, clomiphene citrate (CC) pre-treated with oral contraceptives (OC) (37.93%) was mostly given to obese PCOS patients followed by CC with metformin pre-administered with OC (31.03%), whilen on-obese PCOS patients were mostly administered CC with gonadotropins pre-treated with OC(44%). In single therapy, OC was mostly administered to both non-obese (90%) and obese PCOS patients (88.90%).Conclusion: This study concluded that most of the infertile PCOS women were overweight and obese, a major risk actor causing hyperandrogenicity. CC pre-treated with OC and metformin with CC pre-treated with OC were mostly prescribed to obese PCOS patients. Lifestyle modifications along with treatment are strongly recommended, especially in obese PCOS patients.

scholarly journals Polycystic Ovary Syndrome: Update on Treatment Options and Treatment Considerations for the Future

2011 ◽  
Vol 4 ◽  
pp. CMWH.S6715
Author(s):  
Kristen A. Farrell-Turner
Keyword(s):  
Insulin Resistance ◽  
Polycystic Ovary Syndrome ◽  
Polycystic Ovary ◽  
Treatment Options ◽  
Treatment Modalities ◽  
Ovary Syndrome ◽  
Common Cause ◽  
Endocrine Disorder ◽  
The Future ◽  
Treatment Considerations

Polycystic ovary syndrome is an endocrine disorder characterized by insulin resistance, hyperandrogenemia, obesity, and inflammation, and is the most common cause of infertility. Women with PCOS are at higher risk than non-PCOS women for diabetes, cardiovascular disease, endometrial cancer, and psychiatric disorders. Because many abnormalities present in PCOS and symptoms vary considerably among PCOS women, treatment is guided by presentation and does not consist of simply one modality. Often, however, one type of medication can ameliorate more than one abnormality in PCOS. This review summarizes current research on several treatment modalities for PCOS, including drugs that are fairly well-established as efficacious and other agents that may prove efficacious in the future, with particular emphasis on the benefits and barriers of lifestyle change.

Sign in / Sign up

Export Citation Format

Share Document